Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Growth (Status and Outlook) 2022-2028
- LP 4920355
- 86 Pages
- March 2022
- Medical Devices
The United States Prostate Specific Antigen (PSA) Blood Based Biomarker market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Prostate Specific Antigen (PSA) Blood Based Biomarker market, reaching US$ million by the year 2028. As for the Europe Prostate Specific Antigen (PSA) Blood Based Biomarker landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Prostate Specific Antigen (PSA) Blood Based Biomarker players cover ProteoMediX, Cleveland Diagnostics, Randox, and Roche, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Specific Antigen (PSA) Blood Based Biomarker market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Screening Biomarker
Diagnosis Biomarker
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Diagnostics
Drug Discovery
Personalized Medicine
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
ProteoMediX
Cleveland Diagnostics
Randox
Roche
GENFIT
Nutech Cancer Biomarkers
OGT (Sysmex Group)
Minomic
Creative Diagnostics
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2017-2028
2.1.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Segment by Type
2.2.1 Screening Biomarker
2.2.2 Diagnosis Biomarker
2.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
2.3.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type (2017-2022)
2.4 Prostate Specific Antigen (PSA) Blood Based Biomarker Segment by Application
2.4.1 Diagnostics
2.4.2 Drug Discovery
2.4.3 Personalized Medicine
2.4.4 Others
2.5 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application
2.5.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application (2017-2022)
3 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Player
3.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Players
3.1.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Players (2020-2022)
3.1.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Players (2020-2022)
3.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Prostate Specific Antigen (PSA) Blood Based Biomarker by Regions
4.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Regions (2017-2022)
4.2 Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth (2017-2022)
4.3 APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth (2017-2022)
4.4 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth (2017-2022)
4.5 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth (2017-2022)
5 Americas
5.1 Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2017-2022)
5.2 Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2017-2022)
5.3 Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2017-2022)
6.2 APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2017-2022)
6.3 APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker by Country (2017-2022)
7.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2017-2022)
7.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker by Region (2017-2022)
8.2 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2017-2022)
8.3 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Regions (2023-2028)
10.1.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Regions (2023-2028)
10.1.2 Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
10.1.3 APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
10.1.4 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
10.1.5 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
10.2 Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Country (2023-2028)
10.2.1 United States Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.2.2 Canada Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.2.3 Mexico Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.2.4 Brazil Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.3 APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Region (2023-2028)
10.3.1 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.3.2 Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.3.3 Korea Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.3.4 Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.3.5 India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.3.6 Australia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.4 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Country (2023-2028)
10.4.1 Germany Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.4.2 France Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.4.3 UK Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.4.4 Italy Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.4.5 Russia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.5 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Region (2023-2028)
10.5.1 Egypt Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.5.2 South Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.5.3 Israel Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.5.4 Turkey Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.5.5 GCC Countries Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
10.6 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Type (2023-2028)
10.7 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 ProteoMediX
11.1.1 ProteoMediX Company Information
11.1.2 ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
11.1.3 ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 ProteoMediX Main Business Overview
11.1.5 ProteoMediX Latest Developments
11.2 Cleveland Diagnostics
11.2.1 Cleveland Diagnostics Company Information
11.2.2 Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
11.2.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Cleveland Diagnostics Main Business Overview
11.2.5 Cleveland Diagnostics Latest Developments
11.3 Randox
11.3.1 Randox Company Information
11.3.2 Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
11.3.3 Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Randox Main Business Overview
11.3.5 Randox Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
11.4.3 Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 GENFIT
11.5.1 GENFIT Company Information
11.5.2 GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
11.5.3 GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 GENFIT Main Business Overview
11.5.5 GENFIT Latest Developments
11.6 Nutech Cancer Biomarkers
11.6.1 Nutech Cancer Biomarkers Company Information
11.6.2 Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
11.6.3 Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Nutech Cancer Biomarkers Main Business Overview
11.6.5 Nutech Cancer Biomarkers Latest Developments
11.7 OGT (Sysmex Group)
11.7.1 OGT (Sysmex Group) Company Information
11.7.2 OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
11.7.3 OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 OGT (Sysmex Group) Main Business Overview
11.7.5 OGT (Sysmex Group) Latest Developments
11.8 Minomic
11.8.1 Minomic Company Information
11.8.2 Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
11.8.3 Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Minomic Main Business Overview
11.8.5 Minomic Latest Developments
11.9 Creative Diagnostics
11.9.1 Creative Diagnostics Company Information
11.9.2 Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
11.9.3 Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Creative Diagnostics Main Business Overview
11.9.5 Creative Diagnostics Latest Developments
12 Research Findings and Conclusion
Table 1. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Screening Biomarker
Table 3. Major Players of Diagnosis Biomarker
Table 4. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type (2017-2022)
Table 7. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application (2017-2022)
Table 10. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Player (2020-2022)
Table 12. Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players Head office and Products Offered
Table 13. Prostate Specific Antigen (PSA) Blood Based Biomarker Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Regions (2017-2022)
Table 18. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Country (2017-2022)
Table 20. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type (2017-2022)
Table 22. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application (2017-2022)
Table 24. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Region (2017-2022)
Table 26. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type (2017-2022)
Table 28. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application (2017-2022)
Table 30. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Country (2017-2022)
Table 32. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type (2017-2022)
Table 34. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Prostate Specific Antigen (PSA) Blood Based Biomarker
Table 43. Key Market Challenges & Risks of Prostate Specific Antigen (PSA) Blood Based Biomarker
Table 44. Key Industry Trends of Prostate Specific Antigen (PSA) Blood Based Biomarker
Table 45. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share Forecast by Application (2023-2028)
Table 51. ProteoMediX Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 52. ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 53. ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. ProteoMediX Main Business
Table 55. ProteoMediX Latest Developments
Table 56. Cleveland Diagnostics Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 57. Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 58. Cleveland Diagnostics Main Business
Table 59. Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Cleveland Diagnostics Latest Developments
Table 61. Randox Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 62. Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 63. Randox Main Business
Table 64. Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Randox Latest Developments
Table 66. Roche Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 67. Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 68. Roche Main Business
Table 69. Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Roche Latest Developments
Table 71. GENFIT Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 72. GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 73. GENFIT Main Business
Table 74. GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. GENFIT Latest Developments
Table 76. Nutech Cancer Biomarkers Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 77. Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 78. Nutech Cancer Biomarkers Main Business
Table 79. Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Nutech Cancer Biomarkers Latest Developments
Table 81. OGT (Sysmex Group) Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 82. OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 83. OGT (Sysmex Group) Main Business
Table 84. OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. OGT (Sysmex Group) Latest Developments
Table 86. Minomic Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 87. Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 88. Minomic Main Business
Table 89. Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Minomic Latest Developments
Table 91. Creative Diagnostics Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 92. Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 93. Creative Diagnostics Main Business
Table 94. Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Creative Diagnostics Latest Developments
List of Figures
Figure 1. Prostate Specific Antigen (PSA) Blood Based Biomarker Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type in 2021
Figure 7. Prostate Specific Antigen (PSA) Blood Based Biomarker in Diagnostics
Figure 8. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market: Diagnostics (2017-2022) & ($ Millions)
Figure 9. Prostate Specific Antigen (PSA) Blood Based Biomarker in Drug Discovery
Figure 10. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market: Drug Discovery (2017-2022) & ($ Millions)
Figure 11. Prostate Specific Antigen (PSA) Blood Based Biomarker in Personalized Medicine
Figure 12. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market: Personalized Medicine (2017-2022) & ($ Millions)
Figure 13. Prostate Specific Antigen (PSA) Blood Based Biomarker in Others
Figure 14. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application in 2021
Figure 16. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Player in 2021
Figure 17. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2017-2022 ($ Millions)
Figure 19. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2017-2022 ($ Millions)
Figure 20. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2017-2022 ($ Millions)
Figure 22. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Value Market Share by Country in 2021
Figure 23. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Consumption Market Share by Type in 2021
Figure 24. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application in 2021
Figure 25. United States Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Region in 2021
Figure 30. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application in 2021
Figure 31. China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Country in 2021
Figure 38. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type in 2021
Figure 39. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application in 2021
Figure 40. Germany Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application in 2021
Figure 48. Egypt Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 54. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 55. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 57. United States Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 58. Canada Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 61. China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 62. Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 63. Korea Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 65. India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 66. Australia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 67. Germany Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 68. France Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 69. UK Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 70. Italy Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 71. Russia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 72. Spain Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 75. Israel Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
